|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-02
|
$296,906
|
$74,227
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
14-3-3zeta in Early Stages of Breast Cancer Progression
|
5R01CA109570-05
|
$264,158
|
$66,040
|
Yu, Dihua
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
14-3-3zeta in ErbB2 Mediated Mammary Carcinogenesis
|
5R01CA112567-04
|
$254,494
|
$254,494
|
Yu, Dihua
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
3D-adhesion stromagenesis in cancer permissiveness
|
5R01CA113451-03
|
$235,778
|
$235,778
|
CUKIERMAN, EDNA
|
INSTITUTE FOR CANCER RESEARCH
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) Phase I Clinical Tr
|
1R43CA132257-01A1
|
$140,983
|
$70,492
|
MORGAN, Lee
|
DEKK-TEC, INC.
|
|
A Biomagnetic Sensor for Detecting Breast Cancer
|
5R44CA096154-04
|
$607,760
|
$151,940
|
FLYNN, EDWARD
|
SENIOR SCIENTIFIC
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
1R01CA129484-01A1
|
$393,213
|
$393,213
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Diffusion-Based MRI Method to Detect Glioma Invasion
|
5R21CA109280-02
|
$151,500
|
$151,500
|
SCHMAINDA, KATHLEEN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-02
|
$189,600
|
$189,600
|
HOLMEN, SHERI
|
NEVADA CANCER INSTITUTE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
2R01CA072038-11A1
|
$300,198
|
$99,065
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A laminin peptide increases breast cancer bone metastasis
|
5K22CA116258-02
|
$153,144
|
$153,144
|
KOBLINSKI, JENNIFER
|
NORTHWESTERN UNIVERSITY
|
|
A Mitogen-induced G Protein-coupled Receptor
|
Z01 SC 009389
|
$68,486
|
$68,487
|
Kelly, Kathleen
|
CCR (NCI)
|
|
A mouse model for p120 downregulation in cancer
|
5R01CA111947-04
|
$287,369
|
$287,369
|
REYNOLDS, ALBERT
|
VANDERBILT UNIVERSITY
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
$1,446,104
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A Mouse model of TGFbeta1 and ras oncogene interactions
|
5R01CA122109-03
|
$240,628
|
$60,157
|
GLICK, ADAM
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A mouse model of the zebrafish meltdown mutant
|
5R21CA120491-02
|
$157,500
|
$78,750
|
PACK, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
A New Radiotracer for Sentinel Node Mapping of Colon Cancer
|
5R21CA126037-02
|
$185,400
|
$148,320
|
HOH, CARL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A novel function of TIMP-1
|
2R01CA089113-06A1
|
$269,442
|
$67,361
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
$140,450
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Oncolytic HSP Vaccine for Systemic Tumor Therapy
|
7R01CA100841-03
|
$224,748
|
$112,374
|
HUANG, XUE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A novel osteopontin fragment as a diagnostic/prognostic cancer plasma biomarker
|
1R21CA129849-01A1
|
$169,031
|
$42,258
|
Liaw, Lucy
|
MAINE MEDICAL CENTER
|
|
A Novel Regulator of Cancer Cell Migration and Invasion
|
5R01CA115706-03
|
$215,746
|
$215,746
|
ALAHARI, SURESH
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
A Novel Treatment to Target Tumor Mass for Eradicating Metastasis
|
1R43CA130182-01A1
|
$200,435
|
$200,435
|
Bao, Yun
|
BIOCHAIN INSTITUTE, INC.
|
|
A Pathway of Tumor Suppression
|
5R01CA047296-21
|
$236,943
|
$59,236
|
Lozano, Guillermina
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Phase 2 Trial of Dasatinib in Patients with NSCLC and Acquired Resistance to Er
|
5R21CA130343-02
|
$224,400
|
$224,400
|
MILLER, VINCENT
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Phase I/II Clinical Trial of Intravenous (I.V.) Calcitriol with Fixed Doses of
|
1R21CA128193-01A1
|
$412,976
|
$412,976
|
RAMNATH, NITHYA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer
|
1R21CA128352-01A1
|
$268,452
|
$268,452
|
oh, william
|
DANA-FARBER CANCER INSTITUTE
|
|
A program of immune-based treatments for cancer
|
2K24CA093670-06
|
$178,300
|
$44,575
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
A Risk Prediction Model for Colorectal Cancer Screening
|
1R01CA131197-01A1
|
$389,327
|
$389,327
|
SCHROY, PAUL
|
BOSTON MEDICAL CENTER
|
|
A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction
|
1R01CA127735-01A1
|
$312,288
|
$312,288
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
A simple urinary assay for sensitive prognosis of disease progression and death f
|
5R21CA127671-02
|
$226,445
|
$226,445
|
HILLEGONDS, DARREN
|
UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB
|
|
A Structure/function Analysis of a Tumor Specific Protein
|
5R01CA121289-02
|
$287,850
|
$287,850
|
MALKAS, LINDA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A Transgenic Model for Prostate Tumor Immunity
|
5R01CA109339-05
|
$281,848
|
$70,462
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Abl kinases in growth factor signaling, motility and invasion
|
5R01CA116784-02
|
$269,444
|
$269,444
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
$6,276
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
$15,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
$439,599
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACOSOG Central Specimen Bank
|
5U24CA114736-04
|
$340,041
|
$34,004
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
5R01CA114075-04
|
$280,299
|
$28,030
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
|
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
|
1P01CA128913-01A1
|
$1,670,604
|
$300,709
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Add-on module for ONCAD for diagnosing infiltrating lobular carcinoma
|
1R43CA132259-01A1
|
$100,058
|
$100,058
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
Adenoviral GFP targeting of metastatic human tumors using multiple delivery route
|
1R43CA132242-01
|
$149,575
|
$149,575
|
Kishimoto, Hiroyuki
|
ANTICANCER, INC.
|
|
Adhesion signaling by a novel mitotic substrate of src
|
5R01CA113952-04
|
$255,337
|
$127,669
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Adhesive Regulation During Cell Migration
|
5R01CA085862-09
|
$272,687
|
$272,687
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
3R01CA116195-04S1
|
$86,800
|
$86,800
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-04
|
$321,017
|
$321,017
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-05
|
$337,154
|
$337,154
|
YEE, CASSIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced Ultrasonic Evaluation of Sentinel Lymph Nodes
|
5R01CA100183-03
|
$246,304
|
$246,304
|
Feleppa, Ernest
|
RIVERSIDE RESEARCH INSTITUTE
|
|
AFAP-110 regulates signals that affect F-actin
|
5R01CA060731-14
|
$254,627
|
$254,627
|
Flynn, Daniel
|
WEST VIRGINIA UNIVERSITY
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
5R01CA123194-02
|
$443,966
|
$443,966
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO
|
Total relevant funding to Metastasis for this search: $366,310,151
|